Postoperative glycemic pancreatectomy for control after central mid-gland lesions

被引:49
作者
Allendorf, John D. [1 ]
Schrope, Beth A. [1 ]
Lauerman, Margaret H. [1 ]
Inabnet, William B. [1 ]
Chabot, John A. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
关键词
D O I
10.1007/s00268-005-0382-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Patients undergoing partial pancreatectomy are at risk for developing surgically induced diabetes. Patients with lesions in the neck and body of the pancreas are at increased risk because traditional resectional approaches (pancreaticoduodenectomy or distal pancreatectomy) must be extended to remove the tumor with adequate margins. Increasingly, we have been performing pancreatic parenchyma-sparing resections (central pancreatectomy with pancreaticogastrostomy) in an effort to reduce the risk of postpancreatectomy endocrine insufficiency. Methods: The operative records of patients who underwent pancreatectomy at our institution from 1999 to 2005 were reviewed. We identified 26 patients who underwent central pancreatectomy with pancreaticogastrostomy reconstruction for cystic lesions (n = 23), neuroendocrine tumors (n = 2), and Frantz's tumor (n = 1). Charts were reviewed for patient demographics, volume of resection, complications, and evaluation of postoperative glycemic control. Results: The mean follow-up was 33 months (range 3-72 months). The average volume of pancreas resected was 49.6 +/- 38.6 cm(3), and the mean diameter of the lesions was 2.6 +/- 1.5 cm. Nine complications occurred in eight patients (overall morbidity 31%), and the average length of stay was 6.9 +/- 2.7 days. Pancreatic leaks (n = 2; 7.7%) were successfully managed nonoperatively. There was no operative mortality, and there has been no tumor recurrence. None of the patients were diabetic preoperatively. Postoperatively, two (7.7%) developed endocrine insufficiency with a mean postoperative hemoglobin A1c (HbA1c) value of 7.65%. Neither patient has required exogenous insulin. HbA1c in the remaining patients was 5.9% +/- 0.5%. Conclusions: Pancreatic parenchyma-sparing surgery for lesions in the midportion of the gland can be performed with acceptable morbidity. Postoperative glycemic control after pancreatic parenchyma-sparing surgery compares favorably with that reported for patients with traditional resections.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 32 条
  • [1] MORBIDITY AND MORTALITY AFTER RADICAL AND PALLIATIVE PANCREATIC-CANCER SURGERY - RISK-FACTORS INFLUENCING THE SHORT-TERM RESULTS
    BAKKEVOLD, KE
    KAMBESTAD, B
    [J]. ANNALS OF SURGERY, 1993, 217 (04) : 356 - 368
  • [2] Ten-year experience with 733 pancreatic resections - Changing indications, older patients, and decreasing length of hospitalization
    Balcom, JH
    Rattner, DW
    Warshaw, AL
    Chang, Y
    Fernandez-del Castillo, C
    [J]. ARCHIVES OF SURGERY, 2001, 136 (04) : 391 - 397
  • [3] Surgical treatment of benign and borderline neoplasms of the pancreatic body
    Balzano, G
    Zerbi, A
    Veronesi, P
    Cristallo, M
    Di Carlo, V
    [J]. DIGESTIVE SURGERY, 2003, 20 (06) : 506 - 510
  • [4] Brennan MF, 1996, ANN SURG, V223, P506, DOI 10.1097/00000658-199605000-00006
  • [5] Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis
    Brunicardi, FC
    Chaiken, RL
    Ryan, AS
    Seymour, NE
    Hoffmann, JA
    Lebovitz, HE
    Chance, RE
    Gingerich, RL
    Andersen, DK
    Elahi, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3566 - 3572
  • [6] Microcirculation of the islets of Langerhans - Long Beach Veterans Administration Regional Medical Education Center Symposium
    Brunicardi, FC
    Stagner, J
    BonnerWeir, S
    Wayland, H
    Kleinman, R
    Livingston, E
    Guth, P
    Menger, M
    McCuskey, R
    Intaglietta, M
    Charles, A
    Ashley, S
    Cheung, A
    Ipp, E
    Gilman, S
    Howard, T
    Passaro, E
    [J]. DIABETES, 1996, 45 (04) : 385 - 392
  • [7] The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
    Cabrera, O
    Berman, DM
    Kenyon, NS
    Ricordi, C
    Berggrern, PO
    Caicedo, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (07) : 2334 - 2339
  • [8] Insulin degradation: Progress and potential
    Duckworth, WC
    Bennett, RG
    Hamel, FG
    [J]. ENDOCRINE REVIEWS, 1998, 19 (05) : 608 - 624
  • [9] Central pancreatectomy with pancreaticogastrostomy for benign pancreatic pathology
    Efron, DT
    Lillemoe, KD
    Cameron, JL
    Yeo, CJ
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2004, 8 (05) : 532 - 538
  • [10] Resection of the pancreas - Report of a case.
    Finney, JMT
    [J]. ANNALS OF SURGERY, 1910, 51 : 818 - 829